In the third part of 3 related v-blogs, Dr. Lundberg foresees 10 changes, big and small, for the future of Americans' health.

Most current practitioners have never seen a case of polio. Would you recognize the signs and symptoms?

Dr. Maurie Markman discusses the potential of 'molecular tumor boards' to interpret the genomic and genetic test results of cancer patients who do not have clear treatment options.

Dr. Mark Kris discusses the risks and benefits of using neoadjuvant therapy vs chemoradiation preoperatively for patients with stage IIIA lung cancer.

David Kerr discusses a new 'umbrella review' of vitamin D studies from across the medical literature, and the potential implications for the prevention of colon cancer.

More cases of MERS-CoV in the United States are inevitable. Here's what you should look for, and what to do if you suspect MERS-CoV.

Dr. Maurie Markman considers how genetic ancestry data might be used to predict risk for cancer relapse and inform potential ways to mitigate that risk.

Dr. Mark Kris underscores the advantages of crizotinib and other ALK-targeted therapies for ALK+ lung cancer and looks askance at recent data on toxicity levels and cost-effectiveness of testing.

The Code of Medical Ethics promulgated by the American Medical Association is the underpinning for ethical physician behavior. Are you an adherent?

Even as an advisory panel recommends against national Medicare coverage of lung cancer screening, Dr. Mark Kris stresses the number of lives saved by this well-evidenced means of early detection.